- Home
- BBAI vs IMTX Comparison
BBAI vs IMTX Comparison
Compare BBAI & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBAI | IMTX |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BBAI | IMTX |
|---|---|---|
| Price | $2.59 | $7.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $3.25 | ★ $16.97 |
| AVG Volume (30 Days) | ★ 16.6M | 1.0M |
| Earning Date | 10-27-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 35.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,672,000.00 | N/A |
| Revenue This Year | $23.03 | N/A |
| Revenue Next Year | $7.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.07 | $6.65 |
| 52 Week High | $7.40 | $12.41 |
Technical Indicators
Market Signals| Indicator | BBAI | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 38.52 |
| Support Level | $2.07 | $6.65 |
| Resistance Level | $2.90 | $7.95 |
| Average True Range (ATR) | 0.16 | 0.44 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 87.93 | 26.15 |
Price Performance
Historical ComparisonAbout BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a provider of mission-ready artificial intelligence (AI) technology originally founded to serve defense and national security mission customers. The Company provides Edge AI-powered decision intelligence solutions, including artificial intelligence and machine learning, generative AI, data science, computer vision, biometrics, cyber, cloud solutions, and systems integration. Customers rely on its predictive analytics capabilities in mission-based operating environments. Its solutions are organized into five markets, including Supply Chain & Logistics Solutions, Cybersecurity Solutions, Autonomous Systems Solutions, Digital Identity Services, and the Ask Sage Platform.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.